Clinical effect of metronomic chemotherapy combined with programmed death factor 1/programmed death factor ligand-1 inhibitor in the treatment of stage Ⅲ/Ⅳ non-small cell lung cancer complicated with type 2 diabetes

CHEN Jin-hong; ZHANG Yan; LU Xiao-min

doi:10.16048/j.issn.2095-5561.2021.06.07

Home>Articles>Clinical effect of metronomic chemotherapy combined with programmed death factor 1/programmed death factor ligand-1 inhibitor in the treatment of stage Ⅲ/Ⅳ non-small cell lung cancer complicated with type 2 diabetes

DOI: 10.16048/j.issn.2095-5561.2021.06.07

Clinical effect of metronomic chemotherapy combined with programmed death factor 1/programmed death factor ligand-1 inhibitor in the treatment of stage Ⅲ/Ⅳ non-small cell lung cancer complicated with type 2 diabetes

CHEN Jin-hong

ZHANG Yan

LU Xiao-min

Machine-generated Keywords：

Publication Date：2021-12-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 437-440 )

Trauma and Critical Care Medicine

ISTIC

ISSN：2095-5561

Year, Vol.(Issue)：2021,9(6)